AD HOC NEWS Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1โ36
- Matches
- 40
- Sources here
- 22
- Companies here
- 1
Active search
40 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
EVH | Evolent Health, Inc Class Financials - Revenue Breakdown
This article provides a financial overview of Evolent Health, Inc. (EVH), including its revenue breakdown, Congressional trading activity, and insider trading information. It also details the company's business model, executive compensation, and provides access to various financial data points and analytical tools through the โฆ
Evolent Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:EVH) 2026-08-10
Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA increased 27% to $28 million. Full-year revenue guidance is now $2.6 billionโ$2.7 billion, โฆ
Evolent Health (EVH) Stock Rebounds As Growth Momentum Confronts Losses
Evolent Health (EVH) stock jumped 10% after its Q2 report, showcasing significant revenue growth despite persistent net losses. The company's future hinges on balancing its multi-year revenue expansion from Performance Suite contracts and automation with its ongoing profitability challenges and a low valuation. Investors โฆ
Evolent Health Q2 Earnings Call Highlights
Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA increased 27% to $28 million. Full-year revenue guidance is now $2.6 billionโ$2.7 billion, โฆ
Evolent Health Inc (EVH) (Q2 2026) Earnings Call Highlights: Revenue Surges 31% and Guidance ...
Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA increased 27% to $28 million. Full-year revenue guidance is now $2.6 billionโ$2.7 billion, โฆ
Evolent Health Inc Class A (EVH) Stock Price | Live Quotes & Charts | NYSE
This page provides live stock quotes and charts for Evolent Health Inc Class A (EVH) on the NYSE, showing a current price of $4.26 and an 8.19% decrease. It also notes the absence of analyst ratings or earnings information for the company. The page โฆ
ETFs Investing in Evolent Health Inc Class A Stocks
This article lists various Exchange Traded Funds (ETFs) that hold Evolent Health Inc Class A stocks, providing details such as market value, weight, issuer, management style, focus, expense ratio, and AUM. It highlights that ETFs can make stock investing more accessible and offer diversified โฆ
BlackRock Portfolio Management (NYSE: EVH) discloses 5.5% Evolent Health ownership
BlackRock Portfolio Management LLC has reported a significant ownership stake in Evolent Health, Inc. Class A stock, holding 6,227,355 shares, which represents 5.5% of the outstanding Class A shares as of June 30, 2026. The firm maintains sole voting power over 5,456,212 shares and โฆ